Huang BY, et al. - A retrospective cohort study was conducted to evaluate the 10-year overall survival (OS), progression-free survival (PFS), and local control rates of patients with inoperable stage Ia non-small cell lung cancer (NSCLC) who underwent computed tomography (CT)-guided radiofrequency ablation (RFA) in a single center. Among inoperable patients with inoperable stage Ia NSCLC, CT-guided RFA was feasible and well-tolerated.